Loading clinical trials...
Loading clinical trials...
A Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for Single Dose Administration of TLC599 in Patients With Osteoarthritis (OA) of Knee
Conditions
Interventions
TLC599 LD group
Normal Saline
+1 more
Locations
13
Australia
Genesis Research Services Pty Limited
Broadmeadow, Australia
Pendlebury Clinic Private Hospital
Cardiff, Australia
Footscray Hospital- Western Health
Footscray, Australia
Linear Clinical Research Limited
Nedlands, Australia
Royal North Shore Hospital
Sydney, Australia
Show Chwan Memorial Hospital
Changhua, Taiwan
Start Date
March 16, 2017
Primary Completion Date
July 4, 2018
Completion Date
July 4, 2018
Last Updated
April 22, 2024
NCT06549686
NCT04992624
NCT07193368
NCT06927934
NCT06717529
NCT02116972
Lead Sponsor
Taiwan Liposome Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions